Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;38(5):100707.
doi: 10.1016/j.modpat.2025.100707. Epub 2025 Jan 8.

Clinical, Morphologic, and Genomic Differences in Deep-Penetrating Nevi and Deep-Penetrating Nevus-like Melanomas

Affiliations

Clinical, Morphologic, and Genomic Differences in Deep-Penetrating Nevi and Deep-Penetrating Nevus-like Melanomas

Lu Chen et al. Mod Pathol. 2025 May.

Abstract

Deep-penetrating nevi (DPNs) are characterized by activating mutations in the MAP kinase and Wnt/β-catenin pathways that result in large melanocytes with increased nuclear atypia, cytoplasmic pigmentation, and often mitotic activity. Together with a lack of maturation, this constellation of findings creates challenges for pathologists to distinguish DPN from DPN-like melanoma. To assess the utility of next-generation sequencing (NGS) in resolving this diagnostic dilemma, we performed NGS studies on 35 lesions including 24 DPNs and 11 DPN-like melanomas to characterize the specific genomic differences between the 2 groups and elucidate the genetic events involved in malignant transformation of DPNs. Compared with DPNs, DPN-like melanomas were clinically larger in size (1.1 vs 0.6 cm, P = .02) and on histopathologic examination more frequently showed high-grade nuclear atypia (11/11 vs 9/24; P = .00052), increased mitotic activity (mean 3.9 vs 1.3 per mm2; P = .0004), sheet-like growth pattern (5/11 vs 2/24; P = .01), and involvement of the subcutis (4/5 vs 3/13; P = .026). From a genomic standpoint, DPN-like melanomas had a higher tumor mutation burden (mean 37.1 vs 7.8 mutations/megabase; P = .002) than DPNs and more frequently harbored NRAS mutation (3/11 vs 1/24; P = .046), whereas MAP2K1 in-frame deletions were only identified in DPNs (0/11 vs 5/24). There was no statistically significant difference in the frequency or type of CTNNB1 or APC mutations between the 2 groups. Within progression genes, DPN-like melanomas were more frequently found to have pathogenic variants in TERT promoter (7/11 vs 0/24; P < .00001), CDKN2A (4/11 vs 0/24; P = .0008), and protein subunits of the SWI/SNF complex (7/11 vs 3/24; P = .02) compared with DPNs. Our findings provide a framework for employing NGS in the evaluation of deep-penetrating melanocytic tumors.

Keywords: deep-penetrating nevus; deep-penetrating nevus-like melanoma; malignant melanoma; malignant melanoma arising in association with a deep-penetrating nevus; next-generation sequencing.

PubMed Disclaimer

MeSH terms

LinkOut - more resources